Vincere Biosciences
Developing small molecule therapeutics to protect the body’s most mitochondria-dense organs including the brain, heart, and kidneys by enhancing the cell’s natural ability to clear out damaged mitochondria.
Healthcare & Biotech
Vision
Vincere Biosciences is developing small molecule therapeutics to protect the body’s most mitochondria-dense organs including the brain, heart, and kidneys by enhancing the cell’s natural ability to clear out damaged mitochondria.Built at the intersection of AI-driven discovery and cutting-edge biology, Vincere targets a key driver of age-related decline: dysfunctional mitochondria. With programs advancing toward the clinic, the company is positioned to impact a range of diseases from Parkinson’s disease to cardiorenal conditions - and may more broadly extend healthy human lifespan.
Sub-Industries
Mitochondrial Therapeutics
Age-Related Disease Treatment
Neurodegenerative Disease Therapeutics
Testimonial
Related Companies
KindBio
The future of organ replacement
Salem, NH, USA
The Embryo Corporation
Scalable embryo gene editing to build the next generation of animal life
Austin, TX, USA
Paterna Biosciecnes
In vitro gematogenesis platform company to address male and female intertility
Salt Lake City, UT, USA
Proton Intelligence
Real-time wearable potassium monitoring
Vancouver, Canada
Origenity
AI-driven cell design, from next-generation genetic medicines to expanding what life can be
San Francisco, USA
Deep Root Biolabs
Plant-powered synthetic biology turning polluted soil into clean ground and reclaimed critical minerals
Baltimore, MD, USA
LightHearted AI
Revolutionizing Point-of-Care Cardiac Detection Using Photonics and AI
London, UK
